Visiongain

A new report by Visiongain predicts that the world market for pharma clinical trial services will be worth $30.6bn in 2015. Between 2011 and 2017, the global market will grow with a high single digit CAGR.

Visiongain analysis indicates the global automotive composites market worth $8,85bn in 2013, as vehicle manufacturers increasingly strive reduce vehicle weight to meet emissions regulations and consumers increasingly demand fuel-efficient vehicles.

A new report by visiongain predicts that the world market for generic pharmaceuticals will reach $127.8bn in 2013. That revenue forecast and others appear in Generic Drugs: World Market 2013-2023, published in November 2012.

Visiongain’s analysis indicates that the total value of the global mobile network backhaul equipment market will reach $6.71 billion in 2013.

Visiongain’s analysis indicates that the Gas-to-Liquids Market will reach $5.30bn in 2013.

Until recently, broadband access to the world wide web has been widely regarded as a premium service, not a universal one. However, the changing nature of online media has forced telecoms operators into a corner. They must adapt or perish.

A new report by visiongain predicts that the global market for pharmaceutical contract sales will be worth $3,912m in 2013.

Visiongain’s analysis indicates that the commercial aircraft Parts Manufacture Approval (PMA) market is set to be worth $624.9m in 2013.

A new report by Visiongain, a London-based business information provider, predicts that the global market for diabetes monitoring devices will be worth $27.42bn by 2022. The market generated sales of $9.7bn in 2011.

A new report by visiongain predicts that the world market for AMD and DR drugs will reach $6.25bn in 2015. That revenue forecast and others appear in Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013-2023.